Associated Papers
Genetic disease risks of under-represented founder populations in New York City.
Isshiki M et al.
Plos Genetics, 2025
40554605 (PubMed )
Supplement: pgen.1011755.s006.xlsx › TableS2
Successful kidney transplantation in a patient with late-onset type II Bartter syndrome: A rare case report.
Baligeri K et al.
Clinical Nephrology. Case Studies, 2025
Persistent renal dysfunction post-chemotherapy: a diagnostic conundrum in pediatric cancer survivorship - a case report.
Ding JJ et al.
Bmc Pediatrics, 2024
Genetic disease risks of under-represented founder populations in New York City.
Isshiki M et al.
Medrxiv : the Preprint Server for Health Sciences, 2024
39399040 (PubMed )
Supplement: media-1.xlsx › TableS2
Late-Onset Bartter Syndrome Type II Due to a Novel Compound Heterozygous Mutation in KCNJ1 Gene: A Case Report and Literature Review.
Tian M et al.
Frontiers in Medicine, 2022
Late-Onset Bartter Syndrome Type II Due to a Homozygous Mutation in KCNJ1 Gene: A Case Report and Literature Review.
Elfert KA et al.
The American Journal of Case Reports, 2020
Late-onset Bartter syndrome type II.
Gollasch B et al.
Clinical Kidney Journal, 2017
Late-Onset Bartter's Syndrome Type II with End-Stage Renal Disease Due to a Novel Mutation in KCNJ1 Gene in an Indian Adult Male - A Case Report.
Gaggar P et al.
Indian Journal of Nephrology, 0
Select a paper to view details